Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Current Opinion in Pharmacology|August 7, 2003
Isoform-specific phosphoinositide 3-kinase inhibitors as therapeutic agentsStephen G Ward, Peter FinanJournal of Leukocyte Biology|October 16, 2002
IL-10 expression profiling in human monocytesLynn Williams, Gabor Jarai, Alexandra Smith, et al.Current Topics in Microbiology and Immunology|June 29, 2010
From the bench to the bed side: PI3K pathway inhibitors in clinical developmentSaveur-Michel Maira, Peter Finan, Carlos Garcia-EcheverriaChemistry & Biology|April 3, 2003
Therapeutic potential of phosphoinositide 3-kinase inhibitorsStephen Ward, Yannis Sotsios, James Dowden, et al.Immunity|March 26, 2002
Phosphoinositide 3-kinase gamma is an essential amplifier of mast cell functionMuriel Laffargue, Ronan Calvez, Peter Finan, et al.The Journal of Biological Chemistry|November 17, 2004
Regulation of P-Rex1 by phosphatidylinositol (3,4,5)-trisphosphate and Gbetagamma subunitsKirsti Hill, Sonja Krugmann, Simon R Andrews, et al.Immunology|August 30, 2008
Essential role of phosphoinositide 3-kinase gamma in eosinophil chemotaxis within acute pulmonary inflammationMatthew Thomas, Matthew J Edwards, Elzbieta Sawicka, et al.Molecular Pharmacology|February 28, 2003
Expression and characterization of a 5-oxo-6E,8Z,11Z,14Z-eicosatetraenoic acid receptor highly expressed on human eosinophils and neutrophilsCarol E Jones, Suzanne Holden, Laurent Tenaillon, et al.European Journal of Immunology|March 2, 2005
Airway inflammation: chemokine-induced neutrophilia and the class I phosphoinositide 3-kinasesMatthew J Thomas, Alexandra Smith, Denise H Head, et al.Nature Cell Biology|December 19, 2006
PI(3)Kgamma has an important context-dependent role in neutrophil chemokinesisG John Ferguson, Laura Milne, Suhasini Kulkarni, et al.Pageof 2